SIGA SIGA TECHNOLOGIES INC

NEUTRAL Impact: 2/10 DEFA14A
Horizon days Filed May 8, 2026 Processed 1mo ago SEC 0001140361-26-020020
Proxy solicitation materials
Latest settled — T+5d
SIGA ▼ -6.15% at T+5d
NEUTRAL call ✗ call lost -6.15% · α vs SPY -6.07% · entry $4.55 → $4.27
Next anchor: T+20d due 7d ago
Last close $4.32 (close Jun 12) · -5.05% from $4.55 entry
Entry anchored
May 8, 03:59 PM ET
via Databento tick
T+1d
0.00%
call 0.00% · α +0.14%
$4.55
settled 5w ago
T+5d
-6.15%
call -6.15% · α -6.07%
$4.27
settled 4w ago
T+20d
call — · α —
due 7d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

SIGA Technologies filed a DEFA14A supplement to its 2026 proxy statement, correcting errors in Proposal 4 regarding the amendment to the 2010 Stock Incentive Plan. The corrections remove a non-employee director compensation cap and clarify that the 1,000,000-share annual limit applies only to employees. The board continues to recommend approval of the amendment, which would increase the share pool by 6.5 million shares.

Actionable Insight

Monitor the vote outcome at the June 9, 2026 annual meeting. Passage would enable continued equity grants, while failure could lead to increased cash compensation. The corrective nature of this filing is unlikely to move the stock.

Key Facts

  • The supplement corrects errors in the original proxy statement regarding Proposal 4 (stock plan amendment).
  • Removes erroneous non-employee director compensation cap and clarifies 1,000,000-share limit applies only to employees.
  • Full text of the 2010 Stock Incentive Plan is included as Annex B.
  • Annual meeting scheduled for June 9, 2026; board recommends voting FOR the amendment.
  • The amendment would increase authorized shares from 8.5 million to 15 million (6.5 million new shares).

Financial Impact

No immediate financial impact; the filing is a corrective supplement. If approved, the additional 6.5 million shares represent potential dilution of approximately 12.07% on a fully diluted basis (per company disclosure).

dilution

Risk Factors

  • Failure to approve the amendment could force the company to use cash compensation, potentially impacting cash flow.
  • Approval allows significant equity dilution (12.07% fully diluted overhang), though management claims low burn rate (1.16% 3-year average).

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-020020
Document: 0001140361-26-020020-index-headers.html0001140361-26-020020
Document: 0001140361-26-020020-index.html0001140361-26-020020
Document: 0001140361-26-020020.txt0001140361-26-020020
3 reports for SIGA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SIGA — sortable, filterable
Type Now
May 8, 2026
5w ago
DEFA14A
NEUTRAL ★ 2/10
$4.55 $4.27▼ −6.15%▼ −6.07%$4.32 (−5.05%)
May 7, 2026
5w ago
Press Release
BEARISH ★ 6/10
$4.80 $4.26▲ +11.25%▲ +12.71%$4.32 (+10.00%)
Mar 26, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$4.69 $4.60▼ −1.89%▼ −5.75%$4.32 (−7.86%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 4h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access